Active Pharmaceutical Ingredient

Lacosamide

Also known as: Vimpat; SPM 927

CAS: 175481-36-4 Antiepileptic / Anticonvulsant IP / BP / EP / USP GMP Certified Aurangabad, Maharashtra, India
Lacosamide API — Mediocon Inc
Lacosamide — Pharmaceutical Grade API

Product Overview

CAS No: 175481-36-4  |  MF: C₁₃H₁₈N₂O₃  |  MW: 250.30 g/mol

Lacosamide is a pharmaceutical-grade active ingredient classified as Antiepileptic / Anticonvulsant. Mediocon Inc supplies high-purity Lacosamide API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Key Features

  • Selective sodium channel slow inactivator
  • IP/BP/EP/USP compliant
  • Full CoA and MSDS documentation
  • GMP certified manufacturing

Applications

  • Partial-onset seizures
  • Primary generalised tonic-clonic seizures
  • Diabetic neuropathy (investigational)

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameLacosamide
Also Known AsVimpat; SPM 927
CAS Number175481-36-4
Chemical Name(R)-2-Acetamido-N-benzyl-3-methoxypropionamide
Molecular FormulaC₁₃H₁₈N₂O₃
Molecular Weight250.30 g/mol
CategoryAntiepileptic / Anticonvulsant
AppearanceWhite to off-white powder
SolubilitySoluble in water and methanol
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement
💬
Mediocon AI
Hello 👋 How can I help you today?